Inhibition by retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells.

The activity of type IV collagenase, which enables tumor cells to degrade collagen type IV found in the subendothelial basement membrane, has been correlated with the metastatic potential in several tumor types, including the rat 13762NF mammary adenocarcinoma cell line and its clones. In this study, we examined whether all-trans-retinoic acid (all-trans-RA) and other retinoids, which exhibit antitumor activity in vitro and in vivo, affect the collagenolytic activity of metastatic rat 13762NF mammary adenocarcinoma cells. Cells of the highly metastatic lung-colonizing clone MTF7.T35.3, derived from the 13762NF cell line, were treated for 3 days with 0.1, 1, or 10 microM all-trans-RA, harvested, and seeded on [3H]proline-labeled extracellular matrix deposited by cultured rat lung endothelial cells or on a film of purified [3H]proline-labeled type IV collagen. The amount of radioactivity released into the medium during the subsequent 24 to 72 h was measured, and it was found that all-trans-RA treatment inhibited degradation of extracellular matrix and type IV collagen by 50 to 60%. This effect was observed whether the cells had been treated with all-trans-RA in serum-free medium or in medium supplemented with heat-inactivated or acid-treated fetal bovine serum. The growth of the cells was not inhibited under these conditions, except after treatment with 10 microM all-trans-RA in serum-free medium. The reduction in collagenolytic activity was observed in viable cells as well as in conditioned medium. A 24-h exposure of cells to all-trans-RA was sufficient to cause a 30% decrease in the collagenolytic activity, and this inhibitory effect was reversible. The direct addition of all-trans-RA to conditioned medium had no effect on secreted collagenase activity. The apparent molecular weights of the collagenolytic enzymes were determined by electrophoresis of cell extracts and concentrated conditioned medium in type IV collagen-embedded polyacrylamide gels followed by renaturation and activation of the enzymes within the gels. Two major type IV collagenolytic metalloproteinases exhibiting molecular weights of 64,000 and 88,000, respectively, were detected by this method. These two enzymes were also found to have specificity for gelatin. The Mr 64,000 enzyme could be extracted from viable cells (presumably from the cell membrane) by 2% 1-butanol. Treatment with all-trans-RA decreased the level of these enzymes in the cellular, cell membrane, and conditioned medium compartments.(ABSTRACT TRUNCATED AT 400 WORDS)

[1]  C. Brinckerhoff,et al.  Effect of retinoids on rheumatoid arthritis, a proliferative and invasive non-malignant disease. , 2008, Ciba Foundation symposium.

[2]  H. Tschesche,et al.  Latent and active human polymorphonuclear leukocyte collagenases. Isolation, purification and characterisation. , 2005, European journal of biochemistry.

[3]  I. Fidler,et al.  Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice. , 1988, Cancer research.

[4]  D. Gomez,et al.  Ras oncogene mediated induction of a 92 kDa metalloproteinase; strong correlation with the malignant phenotype. , 1988, Biochemical and biophysical research communications.

[5]  S. Halter,et al.  Effect of retinoids on xenotransplanted human mammary carcinoma cells in athymic mice. , 1988, Cancer research.

[6]  J. Seltzer,et al.  H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. , 1988, The Journal of biological chemistry.

[7]  S. Yamagata,et al.  Gelatinases of metastatic cell lines of murine colonic carcinoma as detected by substrate-gel electrophoresis. , 1988, Biochemical and biophysical research communications.

[8]  T. Irimura,et al.  Heparanases and tumor metastasis , 1988, Journal of cellular biochemistry.

[9]  C. Winterbourn,et al.  Activation of human neutrophil gelatinase by endogenous serine proteinases. , 1988, The Biochemical journal.

[10]  M. Hendrix,et al.  A simple quantitative assay for studying the invasive potential of high and low human metastatic variants. , 1987, Cancer letters.

[11]  T. Salo,et al.  Proteolytic degradation of extracellular matrix in tumor invasion. , 1987, Biochimica et biophysica acta.

[12]  G. Nicolson,et al.  Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. , 1987, Cancer research.

[13]  S. Lippman,et al.  Retinoids as preventive and therapeutic anticancer agents (Part I). , 1987, Cancer treatment reports.

[14]  S. Zucker,et al.  Enrichment of collagen and gelatin degrading activities in the plasma membranes of human cancer cells. , 1987, Cancer research.

[15]  Wen‐Tien Chen,et al.  Fibronectin-degrading proteases from the membranes of transformed cells , 1987, Cell.

[16]  D. Rifkin,et al.  Tumor invasion through the human amniotic membrane: Requirement for a proteinase cascade , 1986, Cell.

[17]  Z. Werb,et al.  Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors. , 1986, The Journal of biological chemistry.

[18]  L. Liotta,et al.  Transient expression of type IV collagenolytic metalloproteinase by human mononuclear phagocytes. , 1986, The Journal of biological chemistry.

[19]  Z. Werb,et al.  Stromelysin, a connective tissue-degrading metalloendopeptidase secreted by stimulated rabbit synovial fibroblasts in parallel with collagenase. Biosynthesis, isolation, characterization, and substrates. , 1985, The Journal of biological chemistry.

[20]  L. Liotta,et al.  Expression of collagenase IV (basement membrane collagenase) activity in murine tumor cell hybrids that differ in metastatic potential. , 1985, Journal of the National Cancer Institute.

[21]  S. Takahashi,et al.  Effects of vitamin A and dexamethasone on collagen degradation in mouse mammary adenocarcinoma. , 1985, Cancer research.

[22]  J. Uitto,et al.  Retinoid modulation of connective tissue metabolism in keloid fibroblast cultures. , 1985, Archives of dermatology.

[23]  J. Uitto,et al.  Modulation of procollagen gene expression by retinoids. Inhibition of collagen production by retinoic acid accompanied by reduced type I procollagen messenger ribonucleic acid levels in human skin fibroblast cultures. , 1985, The Journal of clinical investigation.

[24]  L. Liotta,et al.  NIH/3T3 cells transfected with human tumor DNA containing activated ras oncogenes express the metastatic phenotype in nude mice , 1985, Molecular and cellular biology.

[25]  J. T. Forbes,et al.  Growth inhibition by retinol of a human breast carcinoma cell line in vitro and in athymic mice. , 1984, Cancer research.

[26]  A. Kang,et al.  Heterogeneity among human collagenases demonstrated by monoclonal antibody that selectively recognizes and inhibits human neutrophil collagenase , 1984, The Journal of experimental medicine.

[27]  R. Kramer,et al.  Selective degradation of basement membrane macromolecules by metastatic melanoma cells. , 1984, Journal of the National Cancer Institute.

[28]  R. Lotan,et al.  Stimulation of sialyltransferase activity of melanoma cells by retinoic acid. , 1983, Experimental cell research.

[29]  G P Siegal,et al.  Loss of basement membrane components by invasive tumors but not by their benign counterparts. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[30]  J. Seltzer,et al.  Retinoic acid inhibition of collagenase and gelatinase expression in human skin fibroblast cultures. Evidence for a dual mechanism. , 1983, The Journal of investigative dermatology.

[31]  L. Liotta,et al.  Purification and characterization of a murine basement membrane collagen-degrading enzyme secreted by metastatic tumor cells. , 1983, The Journal of biological chemistry.

[32]  L. Liotta,et al.  Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. , 1982, Biochemistry.

[33]  L. Liotta,et al.  Effect of natural protease inhibitors and a chemoattractant on tumor cell invasion in vitro. , 1982, Journal of the National Cancer Institute.

[34]  H. Birkedal‐Hansen,et al.  Detergent-activation of latent collagenase and resolution of its component molecules. , 1982, Biochemical and biophysical research communications.

[35]  D. Tarin,et al.  Correlation of collagenase secretion with metastatic-colonization potential in naturally occurring murine mammary tumours. , 1982, British Journal of Cancer.

[36]  S. Legrue.  1-Butanol extraction and subsequent reconstitution of membrane components which mediate metastatic phenotype. , 1982, Cancer research.

[37]  J. Seltzer,et al.  Inhibition of collagen degradative enzymes by retinoic acid in vitro. , 1982, Journal of the American Academy of Dermatology.

[38]  G. Nicolson,et al.  Solubilization and degradation of subendothelial matrix glycoproteins and proteoglycans by metastatic tumor cells. , 1982, The Journal of biological chemistry.

[39]  L. Liotta,et al.  Stimulation of retinoic acid of synthesis and turnover of basement membrane in mouse embryonal carcinoma-derived endoderm cells. , 1982, Collagen and related research.

[40]  C. Brinckerhoff,et al.  Modulation by retinoic acid and corticosteroids of collagenase production by rabbit synovial fibroblasts treated with phorbol myristate acetate or poly(ethylene glycol). , 1981, Biochimica et biophysica acta.

[41]  M. Baggiolini,et al.  The latent collagenase and gelatinase of human polymorphonuclear neutrophil leucocytes. , 1980, The Biochemical journal.

[42]  C. Brinckerhoff,et al.  Inhibition by retinoic acid of collagenase production in rheumatoid synovial cells. , 1980, The New England journal of medicine.

[43]  R. Lotan.  Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells. , 1980, Biochimica et biophysica acta.

[44]  L. Liotta,et al.  Metastatic potential correlates with enzymatic degradation of basement membrane collagen , 1980, Nature.

[45]  M. Lippman,et al.  Binding of retinoids to human breast cancer cell lines and their effects on cell growth. , 1980, The Journal of clinical investigation.

[46]  E. Dowdle,et al.  Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. , 1980, Analytical biochemistry.

[47]  I. Fidler,et al.  The pathogenesis of cancer metastasis , 1980, Nature.

[48]  R. Lotan.  Different susceptibilities of human melanoma and breast carcinoma cell lines to retinoic acid-induced growth inhibition. , 1979, Cancer research.

[49]  L. Liotta,et al.  Biochemical interactions of tumor cells with the basement membrane. , 1986, Annual review of biochemistry.

[50]  C. Taylor,et al.  The effects of retinoid treatment and antiestrogens on the growth of T47D human breast cancer cells. , 1986, European journal of cancer & clinical oncology.

[51]  T. Salo,et al.  Effects of retinoids on type IV collagenolytic activity in melanoma cells. , 1986, Acta dermato-venereologica.

[52]  M. Sherman.  Retinoids and cell differentiation , 1986 .

[53]  L. Liotta,et al.  Protein synthesis but not DNA synthesis is required for tumor cell invasion in vitro. , 1984, Invasion & metastasis.

[54]  M. Sporn,et al.  Cellular biology and biochem-istry of the retinoids , 1984 .

[55]  G. Nicolson,et al.  Comparison of 'spontaneous' and 'experimental' metastasis using rat 13762 mammary adenocarcinoma metastatic cell clones. , 1983, Invasion & metastasis.

[56]  G. Nicolson,et al.  Tumor implantation and invasion at metastatic sites. , 1983, International review of experimental pathology.

[57]  U. K. Laemmli,et al.  Cleavage of structural proteins during , 1970 .